The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cleveland Biolabs Inc

Nasdaq: CBLI
Last

(U.S.) $2.00

Today's change+0.05 +2.63%
Updated May 4 3:56 PM -4GMT. Delayed by at least 15 minutes.
 

Cleveland Biolabs Inc

Nasdaq: CBLI
Last

(U.S.) $2.00

Today's change+0.05 +2.63%
Updated May 4 3:56 PM -4GMT. Delayed by at least 15 minutes.

Cleveland Biolabs Inc up sharply

Cleveland Biolabs Inc closed up sharply Wednesday, rallying (U.S.)$0.05 or 2.63% to (U.S.)$2.00. Over the last five days, shares have lost 15.20% and are down 42.66% for the last year to date. This security has underperformed the S&P 500 by 30.30% during the last year.

Key company metrics

  • Open(U.S.) $2.10
  • Previous close(U.S.) $1.95
  • High(U.S.) $2.24
  • Low(U.S.) $1.99
  • Bid / Ask(U.S.) $1.14 / (U.S.) $0.00
  • YTD % change-42.66%
  • Volume19,052
  • Average volume (10-day)23,500
  • Average volume (1-month)17,072
  • Average volume (3-month)27,293
  • 52-week range(U.S.) $1.84 to (U.S.) $7.24
  • Beta1.10
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.69
Updated May 4 3:56 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue1101
Total other revenue--------
Total revenue1101
Gross profit--------
Total cost of revenue--------
Total operating expense3334
Selling / general / administrative1122
Research & development2222
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0------
Other operating expenses, total--------
Operating income-2-3-3-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-3-4-4
Income after tax-2-3-4-4
Income tax, total------0
Net income-1-3-4-4
Total adjustments to net income--------
Net income before extra. items-1-3-4-4
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-3-4-4
Inc. avail. to common incl. extra. items-1-3-4-4
Diluted net income-1-3-4-4
Dilution adjustment------0
Diluted weighted average shares111043
Diluted EPS excluding extraordinary itemsvalue per share-0.13-0.31-1.12-1.14
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.13-0.31-1.12-1.14